[Radiotherapy of hidradenitis suppurativa--still valid today?].
OBJECTIVE
In a retrospective analysis the efficacy of radiotherapy in the treatment of hidradenitis suppurativa was assessed.


METHODS
Data from 231 patients undergoing radiotherapy for hidradenitis suppurativa in the last years in 2 hospitals were analyzed. The patients were treated with an orthovoltage therapy unit with 175 kV, 0.5 mm copper-filtering. The single doses reached from 0.5 Gy to 1.5 Gy up to total doses between 3.0 Gy and 8.0 Gy in one series. In chronic recurrent disease 2 or more series with a total dose of more than 10.0 Gy were given.


RESULTS
Complete relief of symptoms at the end of radiotherapy was achieved in 89 patients (38%). In 92 patients (40%) there was clear improvement of symptoms. Only 2 patients did not react to radiotherapy. No side effects of radiotherapy occurred.


CONCLUSIONS
Radiotherapy should be given more consideration as a treatment option for hidradenitis suppurativa.
Fröhlich
D
D
Klinik für Strahlentherapie, Zentralklinikum, Suhl.
Baaske
D
D
Glatzel
M
M
D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D017497:Hidradenitis Suppurativa / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D012189:Retrospective Studies; D016896:Treatment Outcome